Bessemer Group
VYGR icon

Bessemer Group’s Voyager Therapeutics VYGR Stock Holding History

Bessemer Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Hold
3,513
– – ﹤0.01% 2128
2026
Q1 		$14K Hold
3,513
– – ﹤0.01% 2031
2025
Q4 		$14K Hold
3,513
– – ﹤0.01% 2002
2025
Q3 		$16K Hold
3,513
– – ﹤0.01% 1790
2025
Q2 		$11K Hold
3,513
– – ﹤0.01% 1798
2025
Q1 		$12K Hold
3,513
– – ﹤0.01% 1718
2024
Q4 		$20K Hold
3,513
– – ﹤0.01% 1529
2024
Q3 		$21K Hold
3,513
– – ﹤0.01% 1491
2024
Q2 		$28K Hold
3,513
– – ﹤0.01% 1349
2024
Q1 		$33K Hold
3,513
– – ﹤0.01% 1370
2023
Q4 		$30K Hold
3,513
– – ﹤0.01% 1412
2023
Q3 		$27K Hold
3,513
– – ﹤0.01% 1427
2023
Q2 		$40K Sell
3,513
-35,474
-91% -$367K ﹤0.01% 1411
2023
Q1 		$301K Buy
+38,987
New +$310K ﹤0.01% 827
2018
Q4 		– Sell
-43,636
Closed -$826K – 2065
2018
Q3 		$826K Buy
+43,636
New +$837K ﹤0.01% 622
2017
Q3 		– Sell
-44,828
Closed -$402K – 1896
2017
Q2 		$402K Buy
44,828
+26,763
+148% +$269K ﹤0.01% 906
2017
Q1 		$239K Sell
18,065
-3,753
-17% -$45.5K ﹤0.01% 1050
2016
Q4 		$278K Buy
+21,818
New +$280K ﹤0.01% 1019

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bessemer Group's VYGR Position: Q2 2026 in Review

Bessemer Group held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 3,513 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Bessemer Group first reported a position in VYGR in Q4 2016 and has held it in 18 quarters since. The position peaked at $826K in Q3 2018. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Bessemer Group held 3,513 shares of Voyager Therapeutics worth $12K as of Q2 2026.
  • Bessemer Group left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2128 holding.
  • Bessemer Group first reported a position in Voyager Therapeutics in Q4 2016 and has held it in 18 quarters since.
  • Bessemer Group's Voyager Therapeutics position peaked at $826K in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.